Description
Recombinant monoclonal antibody to APRIL. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma A3D8. This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques.
Target
APRIL
Target Alias Names
TNFSF13, Tumor necrosis factor ligand superfamily member 13, CD256, A proliferation-inducing ligand, TNF- and APOL-related leukocyte expressed ligand 2, TALL-2, TNF-related death ligand 1, TRDL-1
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression